Skip to main content
    I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $70.17
    +2.10 (+3.09%)

    Market Cap: $1.97B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    94%(32/34)
    Avg Surprise
    +101.89%
    Streak
    25 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.09
    Range$-0.13 - $0.17
    14 analysts
    EPS Revisions
    2
    0
    7d
    2
    8
    30d
    EPS Estimate DriftChange to current
    90d ago$0.15-39.7%
    60d ago$0.09+4.5%
    30d ago$0.09+4.5%
    7d ago$0.09+4.5%
    Current$0.09
    Revenue Consensus
    $204M
    Range$203M - $207M
    17 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.66
    Range$1.58 - $1.75
    14 analysts
    Revenue Consensus
    $255M
    Range$241M - $263M
    17 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.66---
    Sep 26EST
    		-$0.09---
    Jun 26
    Reported Aug 3
    		$0.14$-0.22+163.64%Beat-68.9%
    Mar 26
    Reported May 4
    		$0.10N/A+138.46%Beat+0.0%
    Dec 25
    Reported Feb 11
    		$1.65$0.68+142.65%Beat+43.5%
    Sep 25
    Reported Nov 3
    		$0.38$-0.17+323.53%Beat-36.7%
    Jun 25
    Reported Aug 4
    		$0.45$0.20+125.00%Beat+40.6%
    Mar 25
    Reported May 5
    		$0.10N/A+143.48%Beat+129.4%
    Dec 24
    Reported Feb 10
    		$1.15$0.72+59.72%Beat+134.7%
    Sep 24
    Reported Nov 4
    		$0.60$0.08+650.00%Beat+306.9%
    Jun 24
    Reported Aug 6
    		$0.32$-0.11+390.91%Beat+178.0%
    Mar 24
    Reported May 7
    		$-0.34$-0.67+49.25%Beat+35.8%
    Dec 23
    Reported Feb 6
    		$0.49$-0.09+644.44%Beat+390.0%
    Sep 23
    Reported Nov 7
    		$-0.29$-0.57+49.12%Beat+51.7%
    Jun 23
    Reported Aug 1
    		$-0.41$-0.58+29.31%Beat+22.6%
    Mar 23
    Reported May 2
    		$-0.53$-0.70+24.29%Beat+13.1%
    Dec 22
    Reported Feb 7
    		$0.10N/A+118.52%Beat+211.1%
    Sep 22
    Reported Nov 1
    		$-0.60$-0.79+24.05%Beat-57.9%
    Jun 22
    Reported Aug 2
    		$-0.53$-0.63+15.87%Beat-10.4%
    Mar 22
    Reported May 3
    		$-0.61$-0.83+26.51%Beat-1.7%
    Dec 21
    Reported Feb 8
    		$-0.09N/A+80.43%Beat+67.9%
    Sep 21
    Reported Nov 2
    		$-0.38$-0.64+40.63%Beat+2.6%
    Jun 21
    Reported Aug 3
    		$-0.48$-0.66+27.27%Beat+45.5%
    Mar 21
    Reported May 4
    		$-0.60$-0.64+6.25%Beat+10.4%
    Dec 20
    Reported Feb 23
    		$-0.28$-0.48+41.67%Beat+26.3%
    Sep 20
    Reported Nov 2
    		$-0.39$-0.73+46.58%Beat-14.7%
    Jun 20
    Reported Aug 4
    		$-0.88$-1.14+22.81%Beat-175.0%
    Mar 20
    Reported May 5
    		$-0.67$-0.60-11.67%Miss-91.4%
    Dec 19
    Reported Feb 25
    		$-0.38$-0.40+5.00%Beat-72.7%
    Sep 19
    Reported Nov 5
    		$-0.34$-0.41+17.07%Beat-54.5%
    Jun 19
    Reported Aug 6
    		$-0.32$-0.43+25.58%Beat+25.6%
    Mar 19
    Reported May 7
    		$-0.35$-0.38+7.89%Beat+93.1%
    Dec 18
    Reported Feb 26
    		$-0.22$-0.31+29.03%Beat+93.6%
    Sep 18
    Reported Nov 6
    		$-0.22$-0.34+35.29%Beat+94.4%
    Jun 18
    Reported Aug 7
    		$-0.43$-0.48+10.42%Beat-
    Mar 18
    Reported May 4
    		$-5.05$-3.64-38.74%Miss-
    Dec 17
    Reported Feb 28
    		$-3.46$0.00N/AMiss-
    Mar 17
    Reported Jun 29
    		$-3.90$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio30.91EV/EBITDA27.10x
    Price/FCF17.28xFCF Yield5.79%
    Profitability
    Profit Margin15.00%Operating Margin-0.26%
    ROE18.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio8.55xQuick Ratio6.16x
    Trading Statistics
    Beta0.73Avg Volume949.44K
    52-Week High$147.0352-Week Low$38.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$69.05
    SMA 20$70.30
    SMA 50$66.02
    SMA 200$59.90
    EMA 10$69.36
    EMA 20$69.20
    EMA 50$65.63
    EMA 200$66.54

    MACD

    Line: 0.71Signal: 1.20Hist: -0.49

    ADX

    ADX: 27.0+DI: 21.9-DI: 15.6

    Aroon & PSAR

    Aroon Up24.0
    Aroon DownN/A
    PSAR$66.32

    Bollinger Bands

    Upper Band$75.37
    Lower Band$65.23
    %B Position1442%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    53.5

    Momentum Oscillators

    Stoch %K32.1
    Stoch %D36.0
    Williams %R-55.6
    ROC (10d)-0.9%
    Momentum-0.61
    CCI (20d)-33.4
    MFI (14d)48.8

    Volatility Measures

    ATR (14d)$3.17(4.5%)
    StdDev (20d)2.53
    Hist Vol51.8%(High)

    Volume Flow

    VWAP$69.63
    OBV-10.0M
    AD Line4.7M
    CMF (20d)-0.122

    Volume Metrics

    Avg Vol (20d)973.9K
    Vol Ratio0.5x
    VWMA (20d)$70.76

    Pivot Points

    R3$71.45
    R2$70.51
    R1$69.29
    Pivot Point$68.35
    S1$67.13
    S2$66.19
    S3$64.97

    Advanced Oscillators

    TSI5.92
    Ultimate Osc49.3
    KST48.27

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$200.58M$204.58M$269.08M$224.50M$217.09M$201.32M$239.72M$203.19M$195.88M$164.01M$192.51M$153.30M
    Cost of Revenue$29.12M$27.67M$36.07M$31.77M$34.67M$30.71M$35.99M$32.40M$29.84M$24.76M$28.05M$24.38M
    Gross Profit$171.46M$176.91M$233.01M$192.73M$182.41M$170.61M$203.73M$170.79M$166.04M$139.25M$164.45M$128.92M
    Operating Expenses$171.97M$178.03M$186.90M$183.08M$185.73M$172.09M$171.85M$156.47M$160.94M$154.47M$155.16M$142.39M
    R&D$24.70M$25.83M$24.94M$24.21M$26.21M$27.80M$30.34M$26.08M$28.86M$28.85M$31.05M$29.14M
    SG&A$147.28M$152.20M$161.95M$158.87M$159.52M$144.29M$141.51M$130.39M$132.08M$125.62M$124.11M$113.25M
    Operating Income$-514,000$-1,118,000$46.11M$9.64M$-3,316,000$-1,485,000$31.88M$14.32M$5.10M$-15,218,000$9.30M$-13,471,000
    Interest Income$3.74M$3.74M$4.00M$3.98M$4.48M$5.07M$5.55M$5.89M$5.88M$5.92M$5.87M$5.50M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$3.12M$2.40M$50.32M$13.55M$-2,332,000$4.16M$36.64M$20.33M$10.85M$-9,355,000$15.24M$-8,200,000
    Income Tax Expense$2.80M$13.69M$-85,771,000$3.62M$1.26M$1.17M$1.41M$1.83M$1.05M$650,000$477,000$340,000
    Net Income$314,000$-11,294,000$136.09M$9.93M$-3,592,000$2.99M$35.22M$18.50M$9.79M$-10,005,000$14.76M$-8,540,000
    EBITDA$3.74M$3.48M$49.89M$12.86M$-4,309,000$928,000$32.04M$13.88M$3.91M$-16,908,000$7.79M$-12,986,000
    EBIT$-624,000$-1,344,000$46.44M$9.58M$-6,814,000$-907,000$31.11M$14.44M$4.96M$-15,278,000$9.37M$-13,695,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INSP

    Government Contracts

    Gov Obligations (TTM)
    $4.12M
    Gov Obligations / Revenue
    0.4%
    Obligations YoY
    0.4%
    Active Awards
    151
    New Awards (TTM)
    151
    Avg Remaining Term
    2.7 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24226N0449Department of Veterans AffairsDepartment of Veterans Affairs$100503Apr 8, 2026
    36C24226N0576Department of Veterans AffairsDepartment of Veterans Affairs$100302May 29, 2026
    36C25926P0465Department of Veterans AffairsDepartment of Veterans Affairs$50195May 13, 2026
    36C25626N0583Department of Veterans AffairsDepartment of Veterans Affairs$50151Jun 11, 2026
    36C24226N0530Department of Veterans AffairsDepartment of Veterans Affairs$50151May 7, 2026
    36C24926F0066Department of Veterans AffairsDepartment of Veterans Affairs$50151Dec 23, 2025
    36C24226N0260Department of Veterans AffairsDepartment of Veterans Affairs$50151Nov 20, 2025
    36C24225P1403Department of Veterans AffairsDepartment of Veterans Affairs$49900Aug 21, 2025
    36C24526F0078Department of Veterans AffairsDepartment of Veterans Affairs$47337Oct 27, 2025
    36C25026N0434Department of Veterans AffairsDepartment of Veterans Affairs$43417Mar 26, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Free cash flow per share of Inspire Medical Systems, Inc. – HAM:2DR

    This article provides access to the free cash flow per share data for Inspire Medical Systems, Inc. (HAM:2DR) on the TradingView platform. It highlights that the market for this stock on the Hamburg Stock Exchange is...

    TradingView•10/12/26•Neutral

    Learn Why The Bull Case For Inspire Medical Systems (INSP) Could Change Following Shareholder Investigation

    Inspire Medical Systems is facing a shareholder investigation concerning alleged misleading statements regarding its Inspire V product demand, inventory, launch readiness...

    Simply Wall Street•10/11/26•Neutral

    Price to cash flow ratio of Inspire Medical Systems, Inc. – HAN:2DR

    This article provides financial information for Inspire Medical Systems, Inc. (HAN:2DR) on the Hannover Stock Exchange. It specifically highlights the company's price to cash flow ratio. The content appears to be...

    TradingView•10/11/26•Neutral

    Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Picard Medical, Inc. (PMI), Methode Electronics, Inc. (MEI), Inspire Medical Systems, Inc. (INSP), and GRAIL, Inc. (GRAL)

    Johnson Fistel, PLLP is investigating potential claims on behalf of long-term shareholders of Picard Medical, Inc. (PMI), Methode Electronics, Inc. (MEI), Inspire Medical Systems, Inc. (INSP), and GRAIL...

    GlobeNewswire•10/9/26•Bearish

    Inspire Medical Systems Price Target Announced at $65.00/Share by Barclays

    Barclays has set a price target of $65.00 per share for Inspire Medical Systems. This target provides investors with an updated valuation perspective on the company.

    Moomoo•10/7/26•Somewhat-Bullish

    INSP Valuation and Fair Value

    P/E
    30.9x
    Forward P/E
    59.2x
    EV/EBITDA
    27.1x
    P/FCF
    17.3x
    P/B
    2.5x
    See GNG's fair value

    INSP Profitability: Margins, ROIC and FCF

    Gross margin
    86.1%
    Operating margin
    -0.3%
    Net margin
    15.0%
    ROE
    18.0%
    FCF margin
    13.0%
    FCF yield
    5.8%

    INSP Competitors

    CompanyTicker
    Recursion Pharmaceuticals IncRXRX
    Vera Therapeutics IncVERA
    Butterfly Network IncBFLY
    LeMaitre Vascular IncLMAT
    Fortrea Holdings Inc.FTRE
    BioLife Solutions IncBLFS
    Select Medical HoldingsSEM
    Schrodinger IncSDGR

    Sector: Healthcare

    INSP Analyst Ratings

    Consensus
    Hold
    Analysts
    17
    Strong Buy
    0
    Buy
    4
    Hold
    11
    Sell
    1
    Strong Sell
    1

    INSP Bull Case vs Bear Case

    Bull case

    • INSP beat EPS estimates in 100.0% of its last 8 reported quarters.

    Bear case

    • INSP's quarterly revenue changed -7.6% year over year.

    INSP Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    218.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.09
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 8 down

    Frequently Asked Questions About INSP

    Does INSP pay dividends?

    Inspire Medical Systems Inc (INSP) does not currently pay a regular dividend.

    What is INSP's P/E ratio?

    Inspire Medical Systems Inc has a price-to-earnings (P/E) ratio of 30.91.

    What is INSP's market cap?

    Inspire Medical Systems Inc (INSP) has a market capitalization of $1.97B with a current stock price of $70.17.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In